Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma

This publication has 30 references indexed in Scilit:

• PTEN Mutations in Uterine Sarcomas
  Gynecologic Oncology, 2002
• Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
  Proceedings of the National Academy of Sciences, 2001
• Mutational analysis of the PTEN gene in human uterine sarcomas
  American Journal of Obstetrics and Gynecology, 2001
• Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
  The Journal of Pathology, 2001
• Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma
  Human Pathology, 2000
• Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
  Cancer, 2000
• VEGF, flt-1, and KDR/flk-1 as Prognostic Indicators in Endometrial Carcinoma
  Gynecologic Oncology, 2000
• Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
  British Journal of Cancer, 1999
• Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma
  Surgery, 1999
• Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
  The Journal of Pathology, 1998